Shang Hai Zheng Quan Bao·2026-01-09 21:17Core Viewpoint - The controlling shareholder and chairman of Junshi Biosciences, Mr. Xiong Jun, plans to increase his shareholding in the company by at least RMB 100 million over the next 12 months, with a minimum of RMB 50 million allocated for A-shares [2]. Group 1: Shareholding Details - Mr. Xiong Jun currently holds 87,856,618 shares in the company, which includes 87,854,018 A-shares and 2,600 H-shares [3]. - As of the announcement date, Mr. Xiong has cumulatively acquired 100,000 A-shares, representing approximately 0.01% of the total share capital, with a total transaction amount of RMB 3.8384 million [2]. Group 2: Progress of the Shareholding Plan - As of the announcement date, Mr. Xiong and his concerted parties collectively hold 184,083,186 shares, accounting for 17.93% of the total share capital [5]. - The shareholding increase plan is still ongoing, and Mr. Xiong intends to continue purchasing shares during the implementation period [5]. Group 3: Compliance and Regulations - The shareholding increase will comply with relevant regulations from the China Securities Regulatory Commission, Shanghai Stock Exchange, and Hong Kong Stock Exchange regarding changes in equity and sensitive trading periods [7]. - The implementation of this shareholding increase plan will not lead to changes in the company's controlling shareholder or actual controller [7].